The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
Opioids are a class of drugs that “derive from, or mimic, natural substances found in the opium poppy plant”, according to the website of the US-based Johns Hopkins Medicine. Some common opioids ...
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback